Balugrastim

Balugrastim · Teva Branded Pharmaceutical Products R&D, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Balugrastim, covering 2015-01-14 to 2023-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel [Phase 2, Phase 3]